Open original FDA record ↗Recall record
- FDA identifier
- Z-1794-2026
- Company in FDA record
- Beckman Coulter, Inc.
- FDA classification date
- Apr 8, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to manufacturing issue (incorrectly processing) with in vitro multidrug resistant test.
Source facts
- Action
- On 09/08/2025, the firm sent via mail/email an "URGENT FIELD SAFETY NOTICE" to customers informing them that as a result of an internal investigation Beckman Coulter confirmed that Ciprofloxacin (Cp) antimicrobial agent was incorrectly manufactured on MicroScan Neg Multidrug Resistant MIC 1 Lot 2026-05-08. Customers are instructed to: "Review Ciprofloxacin results generated from Lot 2026-05-08 to identify any abnormal or unexpected trends in both susceptible and resistance patterns, or unexpected change in MIC trends, as compared to historical results for that same species (e.g. a sudden, unexplained increase in susceptible or % susceptible results for a species after implementation of Lot 2026-05-08 versus the previous susceptible or % susceptible results for the same species prior to using Lot 2026-05-08). "Discontinue use of this lot and discard per your laboratory guidelines "The laboratory should retain the inventory of other MicroScan Neg Multidrug Resistant MIC 1 lots as they are not impacted by this issue. Note-Beckman Coulter is no longer distributing MicroScan Neg Multidrug Resistant MIC 1 Lot 2026-05-08 For questions - contact Customer Support Center from website: http://www.beckmancoulter.com
- Initiated
- 2025-09-08
- Root cause
- Under Investigation by firm
- Distribution
- International distribution to the country of Poland.
- Recall number
- Z-1794-2026
- Recall status
- Open, Classified
- CDRH record ID
- 219085
- FDA classified
- 2026-04-08
- Recall event number
- 98562